Historical perspective on the pathology of myocardial ischemia/reperfusion injury

Circulation Research

Volumn 113, Issue 4, 2013, Pages 428-438

  Jennings, Robert B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adenine nucleotides; adenosine; ATP depletion; cyclosporine; diazoxide; ischemic preconditioning; myocardial infarction; reperfusion injury

Indexed keywords

ADENINE NUCLEOTIDE; INULIN;

ARTERIAL BLOOD; CELL DEATH; CELL DISRUPTION; DISEASE DURATION; DISEASE SEVERITY; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HIGH ENERGY PHOSPHATE; HUMAN; IN VIVO STUDY; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; METABOLIC DISORDER; MITOCHONDRION; NO REFLOW PHENOMENON; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SARCOLEMMA;

ADENINE NUCLEOTIDES ADENOSINE; ATP DEPLETION; CYCLOSPORINE; DIAZOXIDE; ISCHEMIC PRECONDITIONING; MYOCARDIAL INFARCTION; REPERFUSION INJURY;

ADENINE NUCLEOTIDES; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DOGS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHATES; TIME FACTORS;

EID: 84881627749     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.300987     Document Type: Review

References (77)

1. Leibowitz J. The History of Coronary Heart Disease. Los Angeles: University of California Press; 1976:225.
2. Weigert C. Ueber die pathologischen Gerinnungsvorgänge. Virchows Arch Pathol Anat. 1880;79:87-123.
3. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902.
4. Jennings RB, WartmanWB. Production of a homogeneous myocardial infarction in the dog. Arch Path. 1957;63:580-585.
5. Jennings RB, Crout JR, Smetters GW. Studies of the distribution and localization of potassium in early myocardial ischemic injury. Arch Pathol. 1957;63:586-592.
6. Gettes LS, Cascio WE. Effect of acute ischemia on electrophysiology In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System, Scientific Foundations. 2nd ed. New York, NY: Raven Press; 1991;2021-2054.
7. Ladue JS, Wroblewski F. The significance of the serum glutamic oxalacetic transaminase activity following acute myocardial infarction. Circulation. 1955;11:871-877.
8. Jennings RB, Kaltenbach JP, Smetters GW. Ensymatic changes in acute myocardial ischemic injury; glutamic oxaloacetic transaminase, lactic dehydrogenase, and succinic dehydrogenase. AMA Arch Pathol. 1957;64:10-16.
9. Kaltenbach JP, Jennings RB. Metabolism of ischemic cardiac muscle. Circ Res. 1960;8:207-213.
10. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 1960;70:68-78.
11. Ganote CE. Contraction band necrosis and irreversible myocardial injury. J Mol Cell Cardiol. 1983;15:67-73.
12. Kloner RA, Ganote CE, Whalen DA Jr, Jennings RB. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol. 1974;74:299-422.
13. Kloner RA, Reimer, KA, Jennings RB. Distribution of coronary collateral flow in acute myocardial ischemic injury: effect of propranolol. Cardiovasc Res. 1976;10:81-90.
14. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-644.
15. Jennings RB. Commentary on selected aspects of cardioprotection. J Cardiovasc Pharmacol Ther. 2011;16:340-348.
16. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC Jr, Becker LC, Bulkley BH, Hutchins GM, Schwartz RP Jr, Bailey KR. Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res. 1985;56:651-665.
17. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
18. Humphrey SM, Gavin JB, Herdson PB. The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol. 1980;12:1397-1406.
19. Jennings RB, Steenbergen C Jr, Kinney RB, Hill ML, Reimer KA. Comparison of the effect of ischaemia and anoxia on the sarcolemma of the dog heart. Eur Heart J. 1983;4(suppl H):123-137.
20. Steenbergen C, Hill ML, Jennings RB. Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart. Circ Res. 1987;60: 478-486.
21. Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol. 1981;102:241-255.
22. Jennings RB, Reimer K, Steenbergen C Jr. Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion (Editorial). J Mol Cell Cardiol. 1986;18:769-780.
23. Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res. 1985;57:864-875.
24. Jennings RB, Hawkins HK, Lowe JE, Hill ML, Klotman S, Reimer KA. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol. 1978;92:187-214.
25. Khaw BA, Scott J, Fallon JT, Cahill SL, Haber E, Homcy C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science. 1982;217:1050-1053.
26. Frame LH, Lopez JA, Khaw BA, Fallon JT, Haber E, Powell WJ Jr. Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2. J Clin Invest. 1983;72:535-544.
27. Shen AC, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol. 1972;67:417-440.
28. Whalen DA, Hamilton DG, Ganote CE, Jennings RB. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Path. 1974;74:381-397.
29. Jennings RB, Steenbergen C Jr. Ca2+ion shifts in vivo in reversible and irreversible ischemic injury In: Mochizuchi S, Takeda N, Nagano M, Dhalla NS. The Ischemic Heart Boston, MA: Kluwer Academic Publishers; 1998:151-176.
30. Shen AC, Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol. 1972;67:441-452.
31. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res. 1985;56:262-278.
32. Jennings RB. Cell volume regulation in acute myocardial ischemic injury. Acta Med Scand. 1976;587:83-93.
33. Ganote CE, Jennings RB, Hill ML, Grochowski E. Experimental myocardial ischemic injury. II. Effect of in vivo ischemia on dog heart slice function in vitro. J Mol Cell Cardiol. 1976;8:189-204.
34. Jennings RB, Kaltenbach JP, Sommers HM, Bahr GF, Wartman WB. Studies of the dying myocardial cell. James TN, Keyes JW eds. The Etiology of Myocardial Infarction. Boston, MA: Little Brown and Co; 1963:189-204.
35. Sayen JJ, Sheldon WF, Pierce G, Kuo P. Polarographic oxygen, the epicardial electrogram and muscle contraction in experimental acute regional ischemia. Circ Res. 1958;6:779-798.
36. Braasch W, Gudbjarnason S, Puri PS, Ravens KG, Bing RJ. Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anesthetized dogs. Circ Res. 1968;23:429-438.
37. Kübler W, Spieckermann PG, Regulation of glycolysis in ischemic and anoxic myocardium. J Mol Cell Cardiol. 1970;1:351-377.
38. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation. 1990;82(suppl II):II2-II12.
39. Rouslin W, Erickson JL, Solaro RJ. Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol. 1986;250:H503-H508.
40. Jennings RB, Reimer KA, Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol. 1991;23:1383-1395.
41. Jennings RB, Steenbergen C Jr. Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol. 1985;47:727-749.
42. Jennings RB, Reimer KA, Steenbergen C Jr, Schaper J. Total ischemia III: effect of inhibition of anaerobic glycolysis. J Mol Cell Cardiol. 1989;21(suppl 1):37-54.
43. Reimer KA, Jennings RB, Hill ML. Total ischemia in dog hearts, in vitro 2. High energy phosphate depletion and associated defects in energy metabolism, cell volume regulation, and sarcolemmal integrity. Circ Res. 1981;49:901-911.
44. Sebbag L, Reimer KA, Jennings RB. Elimination of glycolytically-derived ATP markedly accelerates the onset of transmural cell death during myocardial ischemia in vivo in dogs. Circulation. 1996;94:I367.
45. Vander Heide RS, Ganote CE. Increased myocyte fragility following anoxic injury. J Mol Cell Cardiol. 1987;19:1085-1103.
46. Langer GA, Buckberg GD, Tillisch JH. Cardiac ischemia. Part II-Reperfusion and treatment. West J Med. 1987;147:54-61.
47. Okamoto,F, Allen,RS, Buckberg,GD. Studies of controlled reperfusion after ischemia-VIII Regional blood cardioplegic reperfusion on total vented bypass without thoracotomy. A new concept. J Thoracic Cardiovasc Surg. 1986;92(suppl; pt 2):553-563.
48. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
49. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:H1306-H1315.
50. Murry C, Richard V, Reimer K, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during sustained ischemia. Circ Res. 1990;66:913-993.
51. Fleet WF, Johnson TA, Graebner CA, Gettes LS. Effect of serial brief ischemic episodes on extracellular K+, pH, and activation in the pig. Circulation. 1985;72:922-932.
52. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
53. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83:1113-1151.
54. Grover GJ, Garlid KD. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol. 2000;32:677-695.
55. Gross GJ, Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol. 2003;285:H921-H930.
56. Schwartz LM, Reimer KA, Crago MS, Jennings RB. Pharmacological preconditioning with diazoxide slows energy metabolism during sustained ischemia. Exp Clin Cardiol. 2007;12:139-147.
57. Fryer RM, Eells JT, Hsu AK, Henry MM, Gross GJ. Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol. 2000;278:H305-H312.
58. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, Downey JM. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-466.
59. Murry, CE, Richard, VJ, Jennings, RB, Reimer, KA. Preconditioning with ischemia: is the protective effect mediated by free radical-induced myocardial stunning (abstract) Circulation. 1988;78(suppl II):II77.
60. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-H588.
61. Dow J, Kloner RA. Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther. 2007;12:153-163.
62. Hale SL, Mehra A, Leeka J, Kloner RA. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2008;294:H421-H425.
63. Schwartz LM, Lagranka GJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol. 2006;290:H1011-H1018.
64. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194-197.
65. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemiareperfusion injury. Cardiovasc Res. 2003;60:617-625.
66. Griffiths EJ, Halestrap AP. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol. 1993;25:1461-1469.
67. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008; 359:473-481.
68. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation. 2007;115:1895-1903.
69. Inserta J, Ruiz-Meava M, Rodriguez-Sinova A, Barba I, Garcia-Dorado D. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. Antioxid Redox Signal. 2011;14:923-939.
70. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc Res. 2002;55:534-543.
71. Jennings RB, Herdson PB, Sommers HM. Structural and functional abnormalities in mitochondria isolated from ischemic dog myocardium. Lab Invest. 1969;20:548-557.
72. Jennings RB, Sommers HM, Herdson PB, Kaltenbach JP. Ischemic injury in myocardium. Ann N Y Acad Sciences. 1969;156:61-78.
73. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
74. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975;56:978-985.
75. Bolli R, Jerardi MO, Patel BS, et al. Marked reduction in free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is manifestation of reperfusion injury. Circ Res. 1989;65(3):607-622.
76. Bolli R. Mechanism of myocardial "stunning". Circulation. 1990;82:723-738.
77. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia/reperfusion injury. Physiol Rev. 2007;88:581-587.